טוען...

Cantharidin Overcomes Imatinib Resistance by Depleting BCR-ABL in Chronic Myeloid Leukemia

Cantharidin (CTD) is an active compound isolated from the traditional Chinese medicine blister beetle and displayed anticancer properties against various types of cancer cells. However, little is known about its effect on human chronic myeloid leukemia (CML) cells, including imatinib-resistant CML c...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Mol Cells
Main Authors: Sun, Xiaoyan, Cai, Xueting, Yang, Jie, Chen, Jiao, Guo, Caixia, Cao, Peng
פורמט: Artigo
שפה:Inglês
יצא לאור: Korean Society for Molecular and Cellular Biology 2016
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC5223104/
https://ncbi.nlm.nih.gov/pubmed/27989101
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14348/molcells.2016.0023
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!